From RT.com…
Pfizer announced on Thursday that it had submitted a request for an Emergency Use Authorization (EUA) to the Food and Drug Administration (FDA), several weeks after it began submitting trial data from five- to 11-year-olds to the US regulator.
UPDATE: We and @BioNTech_Group officially submitted our request to @US_FDA for Emergency Use Authorization (EUA) of our #COVID19 vaccine in children 5 to <12. pic.twitter.com/72Z2HXlkOx
— Pfizer Inc. (@pfizer) October 7, 2021